Sean B. W. Martin
Net Worth
Last updated:
What is Sean B. W. Martin net worth?
The estimated net worth of Mr. Sean B. W. Martin is at least $15,912,953 as of 1 Nov 2021. He owns shares worth $1,065,238 as insider, has earned $10,130,465 from insider trading and has received compensation worth at least $4,717,250 in Baxter International Inc..
What is the salary of Sean B. W. Martin?
Mr. Sean B. W. Martin salary is $943,450 per year as Senior Vice President & Gen. Counsel in Baxter International Inc..
How old is Sean B. W. Martin?
Mr. Sean B. W. Martin is 62 years old, born in 1963.
What stocks does Sean B. W. Martin currently own?
As insider, Mr. Sean B. W. Martin owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Baxter International Inc. (BAX) | Senior Vice President & Gen. Counsel | 43,855 | $24.29 | $1,065,238 |
What does Baxter International Inc. do?
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Sean B. W. Martin insider trading
Baxter International Inc.
Mr. Sean B. W. Martin has made 4 insider trades between 2020-2021, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 47,001 units of BAX stock on 2 Nov 2020. As of 1 Nov 2021 he still owns at least 43,855 units of BAX stock.
Baxter International key executives
Baxter International Inc. executives and other stock owners filed with the SEC:
- Mr. Cristiano Franzi (62) Senior Vice President & Pres for EMEA
- Mr. Giuseppe Accogli (54) Executive Vice President & Chief Operating Officer
- Mr. James K. Saccaro (52) Executive Vice President & Chief Financial Officer
- Mr. Jose E. Almeida (63) Chairman, Pres & Chief Executive Officer
- Mr. Sean B. W. Martin (62) Senior Vice President & Gen. Counsel